Driven by rapid clinical translation, industrial-scale allogeneic production, and sustained public–private investment, the ...
CollPlant's proprietary rhCollagen to be used in clinical and commercial applications STEMCELL Technologies supports life sciences research with more than 2,500 specialized reagents, tools, and ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies has commercially launched the CellPore™ Transfection System, providing a groundbreaking new technology with the potential to advance ...
Phycin has been selected to receive an award through the ReGen Valley Tech Hub Call for Commercialization Resources, marking ...
TORONTO, Oct. 13, 2025 /PRNewswire/ -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its wholly ...
After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes. California Institute for Regenerative Medicine, Neurona Therapeutics, Vertex ...
NewcelX Ltd. (Nasdaq: NCEL) ("NewcelX" or the "Company"), a clinical-stage biotechnology company advancing regenerative medicine ...
The global cell cryopreservation market size was valued at US$ 14.9 Bn in 2024 and is projected to reach US$ 104.8 Bn by 2035 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback